Genomics is more than family history.

In late 2024, Rhythm Biosciences (ASX:RHY) completed an asset acquisition agreement for the geneType™ business assets with business integration currently underway.

geneType™ continues to offer integrated risk testing for a range of serious conditions.

Disease prediction can allow for personalised preventive health plans to manage risk. Early detection can save lives.

Watch now

Learn more about our breast cancer test with this video featuring Dr. Carolynn Young and Dr. Joel Evans discussing factors that influence breast cancer risk and the clinical utility of geneType™ for Breast Cancer on The Balancing Act.

Take the first step towards personalised, preventative healthcare

Click on a test to learn more

Breast Cancer

Find out if you are at increased risk of developing breast cancer

Providers

Patients

Colorectal Cancer

Find out if you are at increased risk of developing bowel (colorectal) cancer

Providers

Patients

Ovarian Cancer

Find out if you are at increased risk of developing a ovarian cancer

Providers

Patients

Prostate Cancer

Find out if you are at increased risk of developing a prostate cancer

Providers

Patients

Coronary Artery Disease

Find out if you are at increased risk of developing artery disease

Providers

Patients

Type 2 Diabetes

Find out if you are at increased risk of developing type 2 diabetes

Providers

Patients

Multi-Risk Suite

Find out if you are at increased risk of developing a wide range of cancers as well as heart disease and type 2 diabetes

Providers

Patients

Pancreatic Cancer

geneType™ provides lifetime and 10-year risk scores for pancreatic cancer

Providers

Patients

Melanoma

geneType™ provides lifetime and 10-year risk scores for melanoma

Providers

Patients

Atrial Fibrillation

geneType™ provides a 10-year risk score for atrial fibrillation

Providers

Patients

Know disease risk with geneType™ risk assessment.

Simple buccal/saliva collection
Clinically actionable results
Genetic Counselor post-test consultation available for patient or provider peer-to-peer follow up
CLIA certified laboratory providing polygenic risk integrated assessments since 2011

Providers learn more Patients learn more

We support the advancement of personalised, preventative healthcare.

The geneType™ test series outperform traditional risk models.

Let us help you integrate clinical, familial and genetic risk factors to provide a more comprehensive risk profile.

Detecting cancer earlier and maintaining wellness

The power of the combination of the Rhythm and geneType™ capabilities and portfolio has the potential to dramatically improve early detection rates by providing an accessible, affordable, and accurate alternative that could save lives.